{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT06393309",
      "orgStudyIdInfo": {
        "id": "14751"
      },
      "organization": {
        "fullName": "Mazandaran University of Medical Sciences",
        "class": "OTHER"
      },
      "briefTitle": "Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy",
      "officialTitle": "Investigation of Long-term Outcome of Levetiracetam and Valproate in Treatment of Idiopathic Generalized Epilepsy",
      "acronym": "LEVAGE"
    },
    "statusModule": {
      "statusVerifiedDate": "2024-04",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2022-09-03",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2024-03-19",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2024-03-19",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2024-04-26",
      "studyFirstSubmitQcDate": "2024-04-26",
      "studyFirstPostDateStruct": {
        "date": "2024-05-01",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2024-04-30",
      "lastUpdatePostDateStruct": {
        "date": "2024-05-02",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "PRINCIPAL_INVESTIGATOR",
        "investigatorFullName": "Nasim Tabrizi",
        "investigatorTitle": "Associate professor of neurology",
        "investigatorAffiliation": "Mazandaran University of Medical Sciences"
      },
      "leadSponsor": {
        "name": "Mazandaran University of Medical Sciences",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "This study aimed to compare the long-term efficacy and safety of levetiracetam and valproate in treatment of idiopathic generalized epilepsy."
    },
    "conditionsModule": {
      "conditions": [
        "Treatment of Idiopathic Generalized Epilepsy"
      ],
      "keywords": [
        "Levetiracetam",
        "Valproate",
        "Idiopathic generalized epilepsy"
      ]
    },
    "designModule": {
      "studyType": "OBSERVATIONAL",
      "patientRegistry": false,
      "designInfo": {
        "observationalModel": "COHORT",
        "timePerspective": "RETROSPECTIVE"
      },
      "enrollmentInfo": {
        "count": 169,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Levetiracetam",
          "description": "Patients with idiopathic generalized epilepsy who were under treatment with levetiracetam",
          "interventionNames": [
            "Drug: Levetiracetam"
          ]
        },
        {
          "label": "Sodium valproate",
          "description": "Patients with idiopathic generalized epilepsy who were under treatment with valproate",
          "interventionNames": [
            "Drug: Sodium valproate"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Levetiracetam",
          "description": "Patients with idiopathic generalized epilepsy who were under treatment with levetiracetam",
          "armGroupLabels": [
            "Levetiracetam"
          ]
        },
        {
          "type": "DRUG",
          "name": "Sodium valproate",
          "description": "Patients with idiopathic generalized epilepsy who were under treatment with valproate",
          "armGroupLabels": [
            "Sodium valproate"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Seizure free rate",
          "description": "The percent of patients who remained seizure free on treatment",
          "timeFrame": "1 to 5 years"
        },
        {
          "measure": "Time to first seizure",
          "description": "The interval between start of treatment and recurrence of seizure",
          "timeFrame": "1 to 5 years"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Retention rate",
          "description": "The percent of patients who remained on treatment with levetiracetam or valproate",
          "timeFrame": "1 to 5 years"
        },
        {
          "measure": "Time to withdrawal",
          "description": "The interval between start and withdrawal of treatment",
          "timeFrame": "1 to 5 years"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of juvenile myoclonic epilepsy or generalized tonic-clonic seizure alone\n* Regular monotherapy with levetiracetam or sodium valproate\n\nExclusion Criteria:\n\n* Poor drug adherence\n* Pregnancy",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ],
      "studyPopulation": "Adult patients with idiopathic generalized epilepsy (juvenile myoclonic epilepsy or generalized tonic-clonic seizure alone) who are on monotherapy with levetiracetam or sodium valproate",
      "samplingMethod": "PROBABILITY_SAMPLE"
    },
    "contactsLocationsModule": {
      "locations": [
        {
          "facility": "Bu Ali Sina Hospital",
          "city": "Sari",
          "state": "Mazandaran",
          "zip": "4815837477",
          "country": "Iran",
          "geoPoint": {
            "lat": 36.56332,
            "lon": 53.06009
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "NO"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "C562694",
          "term": "Epilepsy, Idiopathic Generalized"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D000077287",
          "term": "Levetiracetam"
        },
        {
          "id": "D014635",
          "term": "Valproic Acid"
        }
      ],
      "ancestors": [
        {
          "id": "D000081",
          "term": "Acetamides"
        },
        {
          "id": "D000577",
          "term": "Amides"
        },
        {
          "id": "D009930",
          "term": "Organic Chemicals"
        },
        {
          "id": "D000085",
          "term": "Acetates"
        },
        {
          "id": "D000144",
          "term": "Acids, Acyclic"
        },
        {
          "id": "D002264",
          "term": "Carboxylic Acids"
        },
        {
          "id": "D011760",
          "term": "Pyrrolidinones"
        },
        {
          "id": "D011759",
          "term": "Pyrrolidines"
        },
        {
          "id": "D006573",
          "term": "Heterocyclic Compounds, 1-Ring"
        },
        {
          "id": "D006571",
          "term": "Heterocyclic Compounds"
        },
        {
          "id": "D010421",
          "term": "Pentanoic Acids"
        },
        {
          "id": "D014631",
          "term": "Valerates"
        },
        {
          "id": "D005232",
          "term": "Fatty Acids, Volatile"
        },
        {
          "id": "D005227",
          "term": "Fatty Acids"
        },
        {
          "id": "D008055",
          "term": "Lipids"
        }
      ]
    }
  },
  "hasResults": false
}